FREAMINE Drug Patent Profile

Which patents cover Freamine, and what generic alternatives are available?

Freamine is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in FREAMINE is amino acids; magnesium acetate; phosphoric acid; potassium acetate; potassium chloride; sodium acetate. There are three hundred and fifty drug master file entries for this compound. Additional details are available on the amino acids; magnesium acetate; phosphoric acid; potassium acetate; potassium chloride; sodium acetate profile page.

Summary for FREAMINE

US Patents:	0
Applicants:	1
NDAs:	1
DailyMed Link:	FREAMINE at DailyMed

US Patents and Regulatory Information for FREAMINE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
B Braun	FREAMINE 8.5%	amino acids	INJECTABLE;INJECTION	016822-001	Approved Prior to Jan 1, 1982		DISCN	No	No
B Braun	FREAMINE III 8.5% W/ ELECTROLYTES	amino acids; magnesium acetate; phosphoric acid; potassium acetate; potassium chloride; sodium acetate	INJECTABLE;INJECTION	016822-007	Jul 1, 1988		DISCN	No	No
B Braun	FREAMINE III 10%	amino acids	INJECTABLE;INJECTION	016822-005	Approved Prior to Jan 1, 1982		DISCN	No	No
B Braun	FREAMINE HBC 6.9%	amino acids	INJECTABLE;INJECTION	016822-006	May 17, 1983		DISCN	No	No
B Braun	FREAMINE II 8.5%	amino acids	INJECTABLE;INJECTION	016822-002	Approved Prior to Jan 1, 1982		DISCN	No	No
B Braun	FREAMINE III 8.5%	amino acids	INJECTABLE;INJECTION	016822-004	Approved Prior to Jan 1, 1982		DISCN	No	No
B Braun	FREAMINE III 3% W/ ELECTROLYTES	amino acids; magnesium acetate; phosphoric acid; potassium chloride; sodium acetate; sodium chloride	INJECTABLE;INJECTION	016822-003	Approved Prior to Jan 1, 1982		DISCN	No	No